News | Stent Grafts | August 19, 2015

Lombard Medical Acquires Endovascular Stent Graft Developer Altura Medical

Acquisition expands Lombard product portfolio with simple, safe and efficient ultra-low-profile endovascular stent graft

Lombard Medical, acquires, Altura Medical, AAA, endovascular aneurysm repair, EVAR, endovascular stent graft

August 19, 2015 — Lombard Medical Inc. a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), announced the acquisition of Silicon Valley-based Altura Medical. Altura is a privately-held, venture-backed company that has developed an innovative, ultra-low-profile endovascular stent graft technology that offers a simple and predictable solution for the treatment of standard AAA anatomies.

The terms of the transaction include the issuance of $15 million of Lombard common stock at $4 per share (3,750,000 shares of Lombard common stock subject to certain lock up conditions), the assumption of $5.5 million in bank debt, and $2.5 million in certain liabilities and transaction-related costs. 

In addition, up to $27.5 million may be paid based on the achievement of certain commercial and regulatory milestones anticipated over the next five years. Under the terms of the agreement, Lombard has the option to pay the additional consideration in either cash or stock.

The Altura endograft system received CE Mark in 2015 and Lombard plans to launch the device in Europe in January 2016, with a broader international rollout later the same year. In the United States, Lombard intends to file for an IDE (Investigational Device Exemption) from the U.S. Food and Drug Administration (FDA) in early 2016, with the intent to begin recruitment for a U.S. clinical study later in 2016.  

“The Altura device offers a new ultra-low-profile stent graft system without compromising the robustness and durability of the wire and graft fabric,” said Prof. Dierk Scheinert, M.D., chairman of the Division of Interventional Angiology, University Hospital Leipzig, Germany.  He noted, “The added benefits of this smart system are the ability to reposition during deployment and place each graft accurately to each renal artery, enabling physicians to utilize all the available aortic neck.  It also removes the need for cannulation and therefore provides a simple, intuitive, safe and consistent deployment system with predictable and shorter procedure times.”

“Many patients who present for AAA repair can be treated quickly and efficiently with minimal hospital stay and recovery times,” said Stuart A. Harlin, M.D., board certified vascular surgeon, Coastal Vascular & Interventional, Pensacola, Florida. “The introduction of an easy-to-deploy AAA stent graft that offers enhanced safety and accuracy on an ultra-low-profile delivery system will allow physicians to treat a large percentage of AAA patients more efficiently in the future.”

For more information:,

Related Content

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts| July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair| May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...
News | Stent Grafts| April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
abdominal aortic aneurysm, AAA, gender differences, women vs. men, endovascular repair, Journal of Vascular Surgery study
News | Endovascular Aortic Repair| April 05, 2017
Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts| January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts| January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts| January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
Sponsored Content | Videos | Artificial Intelligence| December 19, 2016
At RSNA 2016, the key buzzwords were “deep learning,” “machine learning” and “artificial intelligence.” Vendors and m
News | Stent Grafts| December 13, 2016
Lombard Medical Inc. announced that its Altura endovascular stent graft system was featured in a scientific...
Overlay Init